Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2011-04-30
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Benidipine-based Comparison of Angiotensin Receptors, β-blockers, or Thiazide Diuretics in Hypertensive Patients
NCT00135551
Effects of the TNF-alpha Inhibiton on Hemodynamic Parameters in Resistant Hypertension
NCT02743390
Effect of Antihypertensive Agents Over Sleep Apnea
NCT01896661
Risk Factors of Hypertensive Urgencies
NCT00421239
Renin-angiotensin-aldosterone System Polymorphisms in Resistant Hypertension and Adverse Cardiovascular Events
NCT01173029
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Normal subjects
No interventions assigned to this group
AH
Arterial hypertension patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* arterial hypertension for group 1
* at least 5 years standing arterial hypertension
Exclusion Criteria
* metabolic diseases
* family antecedents of hearing loss (except for presbycusis)
* pregnant women
* use of ototoxic drugs (except for anti-hypertensives)
40 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Federal University of São Paulo
OTHER
Faculdade de Medicina de Valenca
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ricardo Rodrigues Figueiredo
M.D, MSc
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ricardo R Figueiredo, MD,MSc
Role: PRINCIPAL_INVESTIGATOR
Otosul, Valença Medical School
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculdade de Medicina de Valença
Valença, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HAS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.